Indian Diabetes drugs market size stood at USD 1,954 Million in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of 16.7% during the forecast period 2019-2028.

Diabetes is rapidly gaining the status of a potential epidemic in India with around 65 million people currently being affected by it. Diabetes is rapidly gaining the status of a potential epidemic in India with around 65 million people currently being affected by. The diabetes market in India has reached a value of around US$ 1,954 Million in 2018. Diabetes is a chronic disease caused by improper production of or response to insulin in the body which causes high blood sugar levels. In order to control the damage caused by the increasing cases of diabetes in the country, the Indian Government is taking initiatives to provide free treatment and insulin to diabetics at government hospitals. The glucose monitoring devices segment is expected to exhibit the highest growth on account of increasing diabetic cases. The self-monitoring devices are still dominating the market because they are relatively easier to use and cheaper.

Market Drivers

The heightening obesity rates, rising stress levels, lack of proper exercise, adoption of sedentary lifestyle, increase in consumption of unhealthy diet, increase in the healthcare expenditures, growing prevalence of diabetes, increased demand of therapeutic drugs, the market for diabetes drugs and diagnostics is expanding robustly in India. In order to control the damage caused by the increasing cases of diabetes in the country, the Indian Government is taking initiatives to provide free treatment and insulin to diabetics at government hospitals. Some of the other factors contributing to the market growth are rapid urbanization, developing healthcare infrastructure, low-cost of drug production, accelerating pharmaceutical contract manufacturing and introduction of advanced technologies.